HEPACAM blocking peptide product blog
Tags: Blocking Peptide; HEPACAM; HEPACAM blocking peptide;
The HEPACAM hepacam (Catalog #MBS9219449) is a Blocking Peptide and is intended for research purposes only. The product is available for immediate purchase.The HEPACAM hepacam product has the following accession number(s) (GI #121945515) (NCBI Accession #Q14CZ8.1) (Uniprot Accession #Q14CZ8). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Involved in regulating cell motility and cell-matrix interactions. May inhibit cell growth through suppression of cell proliferation.
Cellular Location: Cytoplasm. Membrane; Single-pass type I membrane protein; Cytoplasmic side. Note: In MCF-7 breast carcinoma and hepatic Hep 3B2.1-7 and Hep-G2 cell lines, localization of HEPACAM is cell density-dependent. In well spread cells, localized to punctate structures in the perinuclear membrane, cytoplasm, and at cell surface of protusions. In confluent cells, localized predominantly to the cytoplasmic membrane, particularly in areas of cell-cell contacts. Colocalizes with CDH1. Brain, Eye, Liver, Mammary Gland, Spinal Cord tissues are correlated with this protein. Breast Neoplasms, Congenital Abnormalities, Disease Models, Animal, Edema, Kidney Diseases, Liver Diseases, Liver Neoplasms, Neoplasm Metastasis, Nervous System Malformations, Prostatic Diseases are some of the diseases may be linked to HEPACAM Antibody (C-term) Blocking peptide.